MarketPeel
Insider Trading Intelligence
Pricing
…
DE

Daniel Estes

ARQT
DIRECTOR · ARCUTIS BIOTHERAPEUTICS, INC. · CIK 0001702527
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
24,000
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Daniel Estes. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2020
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,000——24,000Feb 27, 2020Mar 3, 2020 ↗
Other insiders · ARQT
Loading peer insiders…
About this filer
CIK 0001702527
ROLE
Director
PRIMARY
ARQT
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001702527DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback